Prior Auth Required

18688 - 10.1001/jama.2023. . PMID: 37768671; PMCID: PMC10540057

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Service10.1001/jama.2023. . PMID: 37768671; PMCID: PMC10540057
Procedure / Service Description

Pharmacy Policy - 9. Coelho T, Marques W Jr, Dasgupta NR, et al.; NEURO-TTRansform Investigators. Eplontersen for Hereditary 10/23 3/24 Transthyretin Amyloidosis With Polyneuropathy. JAMA. 2023 Oct 17;330(15):1448-1458. doi: 10.1001/jama.2023.18688. PMID: 37768671; PMCID: PMC10540057. 10. Wainua (Prescribing information). Wilmington, DE; AstraZeneca Pharmaceuticals LP; 2023 12/23 3/24 11. Gillmore JD, Judge DP, Cappelli F, et al. Efficacy and safety of acoramidis in transthyretin amyloid 1/25

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.